AIMS: The aim of the study was to explore neurometabolic and associated cognitive characteristics of patients with polysubstance use (PSU) in comparison with patients with predominant alcohol use usingproton magnetic resonance spectroscopy. METHODS:Brain metabolite concentrations were examined in lobar and subcortical brain regions of three age-matched groups: 1-month-abstinent alcohol-dependent PSU, 1-month-abstinent individuals dependent on alcohol alone (ALC) and light drinking controls (CON). Neuropsychological testing assessed cognitive function. RESULTS: While CON and ALC had similar metabolite levels, persistent metabolic abnormalities (primarily higher myo-inositol) were present in temporal gray matter, cerebellar vermis and lenticular nuclei of PSU. Moreover, lower cortical gray matter concentration of the neuronal marker N-acetylaspartate within PSU correlated with higher cocaine (but not alcohol) use quantities and with a reduced cognitive processing speed. CONCLUSIONS: These metabolite group differences reflect cellular/astroglial injury and/or dysfunction in alcohol-dependent PSU. Associations of other metabolite concentrations with neurocognitive performance suggest their functional relevance. The metabolic alterations in PSU may represent polydrug abuse biomarkers and/or potential targets for pharmacological and behavioral PSU-specific treatment.
RCT Entities:
AIMS: The aim of the study was to explore neurometabolic and associated cognitive characteristics of patients with polysubstance use (PSU) in comparison with patients with predominant alcohol use using proton magnetic resonance spectroscopy. METHODS: Brain metabolite concentrations were examined in lobar and subcortical brain regions of three age-matched groups: 1-month-abstinent alcohol-dependent PSU, 1-month-abstinent individuals dependent on alcohol alone (ALC) and light drinking controls (CON). Neuropsychological testing assessed cognitive function. RESULTS: While CON and ALC had similar metabolite levels, persistent metabolic abnormalities (primarily higher myo-inositol) were present in temporal gray matter, cerebellar vermis and lenticular nuclei of PSU. Moreover, lower cortical gray matter concentration of the neuronal marker N-acetylaspartate within PSU correlated with higher cocaine (but not alcohol) use quantities and with a reduced cognitive processing speed. CONCLUSIONS: These metabolite group differences reflect cellular/astroglial injury and/or dysfunction in alcohol-dependent PSU. Associations of other metabolite concentrations with neurocognitive performance suggest their functional relevance. The metabolic alterations in PSU may represent polydrug abuse biomarkers and/or potential targets for pharmacological and behavioral PSU-specific treatment.
Authors: Maria Jose Fernández-Serrano; Miguel Pérez-García; Antonio Verdejo-García Journal: Neurosci Biobehav Rev Date: 2010-05-06 Impact factor: 8.989
Authors: Krista Lisdahl Medina; Paula K Shear; John Schafer; Tisha Gangopadhyay Armstrong; Patrick Dyer Journal: Arch Clin Neuropsychol Date: 2004-03 Impact factor: 2.813
Authors: B C Schweinsburg; M J Taylor; O M Alhassoon; J S Videen; G G Brown; T L Patterson; F Berger; I Grant Journal: Alcohol Clin Exp Res Date: 2001-06 Impact factor: 3.455
Authors: D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: Karen D Ersche; Anna Barnes; P Simon Jones; Sharon Morein-Zamir; Trevor W Robbins; Edward T Bullmore Journal: Brain Date: 2011-06-20 Impact factor: 13.501
Authors: Michael E Hoefer; David L Pennington; Timothy C Durazzo; Anderson Mon; Christoph Abé; Diana Truran; Kent E Hutchison; Dieter J Meyerhoff Journal: Alcohol Date: 2014-08-27 Impact factor: 2.405
Authors: Anna E Kirkland; Brittney D Browning; ReJoyce Green; Lorenzo Leggio; Dieter J Meyerhoff; Lindsay M Squeglia Journal: Mol Psychiatry Date: 2022-05-04 Impact factor: 15.992
Authors: Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff Journal: J Clin Exp Neuropsychol Date: 2016-10-03 Impact factor: 2.475